Advertisement
Screener

Heartflow, Inc. (HTFL) Fair Value Adjustment of Warrants

2.8 / 5 stars · 68/120 Roast Me

Heartflow, Inc. Fair Value Adjustment of Warrants

Heartflow, Inc. (HTFL) reported Fair Value Adjustment of Warrants of $43.90 million for the 12-month period ending 2025-12-31, per its 10-Q filed 2026-08-13.

Financial Statements › Cash Flow › Other Cash Flow Items

us-gaap:FairValueAdjustmentOfWarrants · last filed 2026-08-13

  • Heartflow, Inc. fair value adjustment of warrants for the quarter ending 2025-12-31 was $9.31M, a 21.76% decline year-over-year.
  • Heartflow, Inc. fair value adjustment of warrants for the quarter ending 2025-09-30 was $32.12M, a 5390.09% increase year-over-year.
  • Heartflow, Inc. fair value adjustment of warrants for the quarter ending 2025-06-30 was $863.00K, a 77.91% decline year-over-year.
  • Heartflow, Inc. fair value adjustment of warrants for the quarter ending 2025-03-31 was $1.61M.
  • Heartflow, Inc. fair value adjustment of warrants for fiscal 2024 was $16.39M, a 606.68% increase from fiscal 2023.
  • Heartflow, Inc. fair value adjustment of warrants for fiscal 2023 was $2.32M.
Period endFair Value Adjustment of Warrants 3 monthFair Value Adjustment of Warrants 6 monthFair Value Adjustment of Warrants 9 monthFair Value Adjustment of Warrants 12 monthFair Value Adjustment of Warrants 12 month as first filed
2025-12-31$9.31M
derived: 10-Q 12 month − 10-Q 9 month · filed 2026-08-13
$41.43M
derived: sum of 2 quarters · filed 2026-08-13
$42.29M
derived: sum of 3 quarters · filed 2026-08-13
$43.90M
10-Q · filed 2026-08-13
$43.89M
10-K · filed 2026-03-18
2025-09-30$32.12M
10-Q · filed 2025-11-12
$32.98M
derived: sum of 2 quarters · filed 2026-08-13
$34.59M
10-Q · filed 2025-11-12
$46.49M
derived: sum of 4 quarters · filed 2026-08-13
2025-06-30$863.00K
10-Q · filed 2026-08-13
$2.47M
10-Q · filed 2026-08-13
$14.37M
derived: sum of 3 quarters · filed 2026-08-13
$14.96M
derived: sum of 4 quarters · filed 2026-08-13
2025-03-31$1.61M
10-Q · filed 2026-05-14
$13.51M
derived: sum of 2 quarters · filed 2026-05-14
$14.10M
derived: sum of 3 quarters · filed 2026-05-14
$18.00M
derived: sum of 4 quarters · filed 2026-05-14
2024-12-31$11.90M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18
$12.49M
derived: sum of 2 quarters · filed 2026-03-18
$16.40M
derived: sum of 3 quarters · filed 2026-03-18
$16.39M
10-K · filed 2026-03-18
2024-09-30$585.00K
10-Q · filed 2025-11-12
$4.49M
derived: sum of 2 quarters · filed 2025-11-12
$4.49M
10-Q · filed 2025-11-12
2024-06-30$3.91M
10-Q · filed 2025-09-19
$3.90M
10-Q · filed 2025-09-19
2023-12-31$2.32M
10-K · filed 2026-03-18

Similar stocks

Stock NameCountryMarket CapPE Ratio
ICU MEDICAL INC/DE (ICUI)United States$4.153B18.85
PULSE BIOSCIENCES, INC. (PLSE)United States$3.696B-24.47
iRhythm Holdings, Inc. (IRTC)United States$3.651B-281.06
HAEMONETICS CORP (HAE)United States$4.821B36.52
TELEFLEX INC (TFX)United States$5.093B-5.44
MERIT MEDICAL SYSTEMS INC (MMSI)United States$5.212B28.44
AtriCure, Inc. (ATRC)United States$3.089B
MiniMed Group, Inc. (MMED)United States$5.748B-16.85
UFP TECHNOLOGIES INC (UFPT)United States$2.308B28.37
Inspire Medical Systems, Inc. (INSP)United States$1.990B9.55